Document is current
Any future updates will be listed below
-
Authors
Marhelava, Katsiaryna
Fidyt, Klaudyna
Pepek, Monika https://orcid.org/0000-0003-3506-8040
Krawczyk, Marta https://orcid.org/0000-0001-9487-1744
Forcados, Christopher
Malinowska, Agata
Swiderska, Bianka
Fernandez-Fuentes, Narcis https://orcid.org/0000-0002-6421-1080
Czerwik, Natalia
Baranowska, Iwona
Krzywdzinska, Agnieszka https://orcid.org/0000-0002-7647-3336
Sedek, Lukasz
Slota, Lukasz
Perkowski, Bartosz
Villatoro, Alicia
Leray, Thibault
Lech-Maranda, Ewa
Menendez, Pablo
Inderberg, Else Marit
Wälchli, Sébastien
Winiarska, Magdalena
Firczuk, Malgorzata https://orcid.org/0000-0002-1719-5233
- License Information
-
More Information
Article History
Received: 6 September 2024
Revised: 27 February 2025
Accepted: 19 March 2025
First Online: 5 April 2025
Competing interests
: PM is a cofounder of OneChain Immunotherapeutics, a spin-off company from the Josep Carreras Leukemia Research Institute.
